Schizophrenia Clinical Trial
Official title:
Non-Invasive Brain Stimulation for Clinical Intervention for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients
The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing novel neuromodulation approaches using transcranial direct current stimulation (tDCS) for treating schizophrenia patients with medication-resistant auditory hallucinations. The investigators will use tDCS to stimulate prefrontal cortex. TDCS is a non-invasive brain stimulation technique that can modulate brain connectivity. Non-invasive brain neuromodulation will be combined (paired-neuromodulation) with training of a task that requires top-down control of auditory processes. Paired-neuromodulation can potentially be used as a therapeutic intervention to decrease auditory hallucinations in schizophrenia.
25% of schizophrenia (SZ) patients report chronic auditory hallucinations (AH) despite being
on medication. Previous research proposed that hyperactivity of the left temporo-parietal
cortex (11) and hypoactivity in left dorsolateral prefrontal cortex (DLPFC) (12) are
associated with the onset of AH. While temporal cortex hyperactivity has been extensively
manipulated with neuromodulation interventions trying to reduce AH, results have not been
consistent (1,13). Recent transcranial direct current stimulation (tDCS) work that targeted
both regions above by applying excitatory stimulation over the left DLPFC and inhibitory
stimulation on the left temporo-parietal cortex reported a 30% reduction in AH in patients
with medication refractory AH that lasted up to 3 months after treatment (14). The
investigators are interested to further investigate whether the use of paired
neuromodulation (P-NM) with tDCS in co-targeting top-down executive control with bottom-up
sensory processes would result in a larger reduction in AH. To date, there are no studies
that have used P-NM to examine the magnitude of plasticity of executive control on sensory
processing in SZ patients. This type of P-NM would be relevant since AH are thought to be
the result of a lack of top-down control over perceptual distortions of internally generated
speech. In the forced-attention dichotic listening task (DL), two different syllables are
simultaneously presented to the left and the right ear. Subjects are required to pay
attention to and report either the left or right ear stimulus. Due to the preponderance of
the contralateral pathways, the right ear syllable is projected to the left temporal lobe
for processing, while the left ear stimulus is projected to the right temporal lobe and has
to be transferred across the corpus callosum to be processed in the left hemisphere. Healthy
controls show a right ear advantage (REA) while SZ patients do not (15). DL task performance
requires top-down control over auditory cortex and has been associated with increased DLPFC
activation in controls (16). Worse performance in this task has been associated with greater
severity of AH (17).
SPECIFIC AIMS: The overall aim is to examine the efficacy of tDCS intervention combined with
sensory gating training (paired neuro-modulation; P-NM) to reduce hallucinations (as
measured by Positive and Negative Syndrome Scale and the Auditory Hallucination Rating
Scale). The investigators will collect pilot data to explore the magnitude of DLPFC
plasticity during executive control on auditory processing using P-NM and its effect on
hallucination-related behavior. The investigators will combine tDCS to enhance left DLPFC
activity with auditory stimuli presented to the right ear. The investigators will use the DL
task to assess plasticity of top-down control over auditory sensory perception before and
after intervention. The investigators will correlate DL task performance to the magnitude of
left DLPFC plasticity and with AH severity.
The investigators hypothesize that (a) DLPFC enhancement will facilitate REA in SZ patients
by supporting inhibition of attention to irrelevant syllable and facilitating attention to
the right ear syllable; (b) continued pairing of left DLPFC activity and auditory processing
will reduce auditory hallucinations (as measured by Positive and Negative Syndrome Scale and
the Auditory Hallucination Rating Scale).
Methods: The investigators will recruit 50 SZ patients with persistent severe AH despite
medication as measured by the Positive and Negative Syndrome Scale and the Auditory
Hallucination Rating Scale (AHRS). To examine the effects of P-NM over time, patients will
receive transcranial direct current stimulation (tDCS) during five days, twice a day while
they practice the dichotic listening task (DL; Hugdahl 2013). During the DL task, patients
will be presented with consonant-vowel syllables via headphones. The syllables will consist
of paired presentations of the six stop-consonants /b/, /d/, /g/, /p/, /t/, and /k/ together
with the vowel /a/ to form dichotic consonant-vowel syllable pairs of the type /ba - ga/,/ta
- ka/ etc. The syllables were paired with each other for all possible combinations, thus
yielding 36 dichotic pairs, including the homonymic pairs. Patients will be given two
different instructions. In one instruction condition they will be told to focus attention to
and report from the right ear, and if think they hear something in the left ear, this should
be ignored ("forced-right" condition). In the other condition, patients will be asked to
focus attention to and report from the left ear, and if they think that they hear something
in the right ear, this should be ignored ("forced-left" condition).
Participants will receive either active tDCS treatment or sham stimulation while performing
the DL task. Half of them (n=25) will receive either (a) electrical stimulation (2mA) for 20
minutes to the left DLPFC to enhance top-down control and improve the tuning or gating of
the extraneous information or (b) while the other half will receive sham stimulation to
control for placebo effects. Active tDCS and sham tDCS will be performed with the same tDCS
equipment. The difference is that while active tDCS will be configured to reach constant 2mA
stimulation for 20 minutes, sham tDCS will be a very brief 2mA stimulation for 30 seconds.
During sham tDCS the subject believes he/she is being stimulated normally, but there should
not be any real effects. This same procedure will be repeated during five days, twice a day.
At the end of day 5 all patients will complete the Positive and Negative Syndrome Scale and
the AHRS to evaluate change in AH. Patients will be asked to complete these scales 3, 6, and
9 months after tDCS intervention to examine long-term effects.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |